{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:01:08Z","timestamp":1769691668185,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,25]],"date-time":"2017-02-25T00:00:00Z","timestamp":1487980800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00403-017-1722-7","type":"journal-article","created":{"date-parts":[[2017,2,25]],"date-time":"2017-02-25T06:52:18Z","timestamp":1488005538000},"page":"203-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Can signal peptide-CUB-EGF domain-containing protein (SCUBE) levels be a marker of angiogenesis in patients with psoriasis?"],"prefix":"10.1007","volume":"309","author":[{"given":"Arzu Ayd\u0131n","family":"Capkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selim","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Mentese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c7a\u011flar","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Ayar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,25]]},"reference":[{"issue":"9997","key":"1722_CR1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Schon MP (2015) Psoriasis. Lancet 386(9997):983\u2013994","journal-title":"Lancet"},{"key":"1722_CR2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/039463200902200214","volume":"22","author":"A Campanati","year":"2009","unstructured":"Campanati A, Goteri G, Simonetti O, Ganzetti G, Giuliodori K, Giuliano A (2009) Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. Int J Immunopathol Pharmacol 22:371\u2013377","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1722_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molimm.2014.12.014","volume":"64","author":"A Chandra","year":"2015","unstructured":"Chandra A, Ray A, Senapati S, Chatterjee R (2015) Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol 64:313\u2013323","journal-title":"Mol Immunol"},{"key":"1722_CR4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","volume":"180","author":"M Detmar","year":"1994","unstructured":"Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF (1994) Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141\u20131146","journal-title":"J Exp Med"},{"key":"1722_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3949\/ccjm.82gr.15002","volume":"82","author":"A -Fernandez","year":"2015","unstructured":"Fernandez A (2015) Dermatology update: the dawn of targeted treatment. Cleve Clin J Med 82:309\u2013320","journal-title":"Cleve Clin J Med"},{"key":"1722_CR6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1523-1747.ep12625746","volume":"59","author":"J Folkman","year":"1972","unstructured":"Folkman J (1972) Angiogenesis in psoriasis: therapeutic implications. J Invest Dermatol 59:40\u201343","journal-title":"J Invest Dermatol"},{"key":"1722_CR7","doi-asserted-by":"crossref","first-page":"a006486","DOI":"10.1101\/cshperspect.a006486","volume":"2","author":"S Goel","year":"2012","unstructured":"Goel S, Wong AH, Jain RK (2012) Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. Cold Spring Harb Perspect Med 2: a006486.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1722_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","volume":"135","author":"JE Gudjonsson","year":"2004","unstructured":"Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1\u20138","journal-title":"Clin Exp Immunol"},{"key":"1722_CR9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","volume":"90","author":"R Heidenreich","year":"2009","unstructured":"Heidenreich R, Rocken M, Ghoreschi K (2009) Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol 90:232\u2013248","journal-title":"Int J Exp Pathol"},{"key":"1722_CR10","first-page":"39","volume":"286","author":"YC Lin","year":"2011","unstructured":"Lin YC, Chen CC, Cheng CJ, Yang RB (2011) Domain and functional analysis of a novel breast tumor suppressor protein, SCUBE2. J Biol Chem 286:39\u201347","journal-title":"J Biol Chem"},{"key":"1722_CR11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/jbmr.2451","volume":"30","author":"YC Lin","year":"2015","unstructured":"Lin YC, Roffler SR, Yan YT, Yang RB (2015) Disruption of Scube2 impairs endochondral bone formation. J Bone Miner Res 30:1255\u20131267","journal-title":"J Bone Miner Res"},{"key":"1722_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1242\/jcs.132779","volume":"127","author":"YC Lin","year":"2014","unstructured":"Lin YC, Lee YC, Li LH, Cheng CJ, Yang RB (2014) Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition. J Cell Sci 127:85\u2013100","journal-title":"J Cell Sci"},{"key":"1722_CR13","first-page":"97","volume":"18","author":"W Li","year":"2014","unstructured":"Li W, Man XY, Chen JQ, Zhou J, Cai SQ, Zheng M (2014) Targeting VEGF\/VEGFR in the treatment of psoriasis. Discov Med 18:97\u2013104","journal-title":"Discov Med"},{"key":"1722_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2014.01.068","volume":"540","author":"A Mezentsev","year":"2014","unstructured":"Mezentsev A, Nikolaev A, Bruskin S (2014) Matrix metalloproteinases and their role in psoriasis. Gene 540:1\u201310","journal-title":"Gene"},{"key":"1722_CR15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/CBM-2012-00285","volume":"11","author":"A Mentese","year":"2012","unstructured":"Mentese A, Fidan E, Sumer AU, Karahan SC, Sonmez M, Altay DU (2012) Is SCUBE 1 a new biomarker for gastric cancer? Cancer Biomark 11:191\u2013195","journal-title":"Cancer Biomark"},{"key":"1722_CR16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1468-3083.2009.03181.x","volume":"23","author":"A Nofal","year":"2009","unstructured":"Nofal A, Al-Makhzangy I, Attwa E, Nassar A, Abdalmoati A (2009) Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control. J Eur Acad Dermatol Venereol 23:803\u2013806","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1722_CR17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM (2013) Identification and management of psoriasis and associated comorbidity project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133:377\u2013385","journal-title":"J Invest Dermatol"},{"key":"1722_CR18","doi-asserted-by":"crossref","first-page":"21264","DOI":"10.1073\/pnas.0907550106","volume":"106","author":"HB Schonthaler","year":"2009","unstructured":"Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF (2009) Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc Natl Acad Sci USA 106:21264\u201321269","journal-title":"Proc Natl Acad Sci USA"},{"key":"1722_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1074\/jbc.M113.507954","volume":"289","author":"CF Tu","year":"2014","unstructured":"Tu CF, Tsao KC, Lee SJ, Yang RB (2014) SCUBE3 (signal peptide-CUB-EGF domain-containing protein 3) modulates fibroblast growth factor signaling during fast muscle development. J Biol Chem 289:28\u201342","journal-title":"J Biol Chem"},{"key":"1722_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaad.2015.03.041","volume":"73","author":"G Varricchi","year":"2015","unstructured":"Varricchi G, Granata F, Loffredo S, Genovese A, Marone G (2015) Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J Am Acad Dermatol 73:144\u2013153","journal-title":"J Am Acad Dermatol"},{"key":"1722_CR21","first-page":"682","volume":"30","author":"YY Wu","year":"2011","unstructured":"Wu YY, Peck K, Chang YL et al (2011) SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the epithelial mesenchymal transition in lung cancer. Oncogene 30:682\u2013693","journal-title":"Oncogene"},{"key":"1722_CR22","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.mehy.2013.09.001","volume":"81","author":"M Yanga","year":"2013","unstructured":"Yanga M, Mingyang G, Yonghe H Jiang Y (2013) Scube regulates synovial angiogenesis-related signaling. Med Hypotheses 81:948\u2013953","journal-title":"Med Hypotheses"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1722-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-017-1722-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1722-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T11:23:33Z","timestamp":1498389813000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-017-1722-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,25]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1722"],"URL":"https:\/\/doi.org\/10.1007\/s00403-017-1722-7","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,25]]}}}